SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001415889-15-002479
Filing Date
2015-07-28
Accepted
2015-07-28 16:06:30
Documents
2
Period of Report
2015-07-24

Document Format Files

Seq Description Document Type Size
1 PRE 14A pre14avsta_july2015.htm PRE 14A 244812
2 vista1.jpg GRAPHIC 7191
  Complete submission text file 0001415889-15-002479.txt   255941
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: PRE 14A | Act: 34 | File No.: 000-54014 | Film No.: 151009761
SIC: 2834 Pharmaceutical Preparations